These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10485057)

  • 21. Detection of c-fos expression in benign and malignant musculoskeletal lesions.
    Weisstein JS; Majeska RJ; Klein MJ; Einhorn TA
    J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raloxifene can reduce giant cell tumor recurrence: a new adjuvant therapy.
    Namazi H
    Ann Surg Oncol; 2008 Jun; 15(6):1783-4. PubMed ID: 18157574
    [No Abstract]   [Full Text] [Related]  

  • 23. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors.
    Svoboda M; Thalhammer T; Aust S; Arrich F; Assadian O; Toma CD
    J Surg Oncol; 2007 Jun; 95(7):572-81. PubMed ID: 17230544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actions of 5alpha-reductase inhibitors on the epididymis.
    Robaire B; Henderson NA
    Mol Cell Endocrinol; 2006 May; 250(1-2):190-5. PubMed ID: 16476520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current limitations to the histopathological diagnosis of some frequently encountered bone tumours.
    Galant C; Malghem J; Sibille C; Docquier PL; Delloye C
    Acta Orthop Belg; 2008 Feb; 74(1):1-6. PubMed ID: 18411594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
    Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
    Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of selected immunocytochemical diagnostic markers in the case of chondrosarcoma with a mesenchymal component.
    Rzeszutko W; Dziegiel P; Rzeszutko M; Wojnar A
    Folia Morphol (Warsz); 2003 Nov; 62(4):513-5. PubMed ID: 14655155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor and 5alpha-reductase are expressed in pelvic endometriosis.
    Carneiro MM; Morsch DM; Camargos AF; Reis FM; Spritzer PM
    BJOG; 2008 Jan; 115(1):113-7. PubMed ID: 17983420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid receptors in malignant skeletal tumors.
    Walker MJ; Chaudhuri PK; Beattie CW; Das Gupta TK
    Cancer; 1980 Jun; 45(12):3004-7. PubMed ID: 6930316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of VEGF isoforms and VEGF receptors in cartilaginous tumors.
    Yukata K; Matsui Y; Goto T; Kubo T; Yasui N
    Anticancer Res; 2005; 25(2A):955-7. PubMed ID: 15868933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calmodulin level in chondrosarcomas].
    Kushlinskiĭ NE; Solov'ev IuN; Galkina NM; Aliev MD; Kharatishvili TK; Babkina NV; Berezov TT; Trapeznikov NN
    Biull Eksp Biol Med; 2000 Feb; 129(2):198-200. PubMed ID: 10732246
    [No Abstract]   [Full Text] [Related]  

  • 33. [Concentration of copper and manganese in experimental animal tumors and human bone sarcomas].
    Shevchenko SD; Pankov EIa
    Biull Eksp Biol Med; 1970 Jan; 69(1):75-6. PubMed ID: 5270988
    [No Abstract]   [Full Text] [Related]  

  • 34. Matrix metalloproteinases participate in osteosarcoma invasion.
    Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
    J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cytokines on in vitro bone resorption by cells isolated from giant cell tumor of bone.
    Wen J; Xie D; Yao J; Zhang M; Bi J
    Chin Med J (Engl); 1999 May; 112(5):443-7. PubMed ID: 11593516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estradiol-17beta receptors in the cytosol fraction in chondrosarcomas].
    Kushlinskiĭ NE; Solov'ev IuN; Galkina NM; Aliev MD; Babkina NV; Berezov TT; Trapeznikov NN
    Biull Eksp Biol Med; 2000 Feb; 129(2):201-3. PubMed ID: 10732254
    [No Abstract]   [Full Text] [Related]  

  • 37. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
    Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
    Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and significance of AR in osteosarcoma].
    Liu J; Chen X; Li S; Yue X; Li Y
    Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):344-5, 23. PubMed ID: 11832052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of giant cell tumor, fibrosarcoma and chondrosarcoma].
    Abe M
    Seikei Geka; 1969 Jan; 20(2):168-72. PubMed ID: 5814542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.